Key Influencer in the Fetal Bovine Serum Market 2025: Surging Demand Drives Growth In The Fetal Bovine Serum Market Driver

What industry-specific factors are fueling the growth of the fetal bovine serum market?
The surge in the need for biopharmaceuticals is predicted to stimulate the expansion of the fetal bovine serum market during the forecast period. Biopharmaceuticals are medical products made from biological sources such as animals, humans, and microbes via biotechnology. Fetal bovine serum (FBS) is commonly used as a replacement for animal cell culture medium. Pharmaceutical companies, diagnostic labs, and researchers heavily depend on FBS for much of their cellular culture needs in biologics research. ProClinical Limited, a British lifesciences service and consultancy firm, realized sales of US$36.15mn in 2022 for the company's pharmaceuticals and vaccine segments, marking an 11% year-on-year growth. Hence, the escalating demand for biopharmaceuticals fuels the expansion of the fetal bovine serum market.

Get Your Fetal Bovine Serum Market Report Here:
https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report

What Is the projected market size and growth rate for the fetal bovine serum market?
The market scale of fetal bovine serum has experienced significant growth in the past few years. The market is projected to expand from a value of $1.02 billion in 2024 to $1.07 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.6%. The substantial growth during the historic period is primarily due to the development of the biopharmaceutical industry, an increase in cell-based therapies, and the need for quality and consistency.

There is an anticipation of robust expansion in the market size of fetal bovine serum in the upcoming years, with forecasts predicting a growth to $1.34 billion by 2029, thanks to a compound annual growth rate (CAGR) of 5.7%. The projected surge in the forecast span can be credited to the rising implementation of cell treatments, emergence of superior therapeutics, concentration on alternatives that do not involve animals, as well as strategic alliances between suppliers and customers. Significant trends for the forecast period encompass a focus on product quality and traceability, global collaboration and partnerships, strategic mergers and acquisitions, tailor-made fetal bovine serum products, and consistent adherence to regulations and ethical sourcing.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp

What new trends are reshaping the fetal bovine serum market and its opportunities?
A growing trend in the fetal bovine serum market is the surge in partnerships between corporations and research institutions. Major firms are joining forces to enhance their production capabilities, broaden their market presence, and innovate new products. For example, GE Healthcare, a US company, partnered with Oritain, a company based in New Zealand, to create a distinct test that can identify the origin country of fetal bovine serum (FBS). This would aid biomanufacturing organizations, as FBS obtained from varying countries presents distinct levels of virus contamination risk.

What major market segments define the scope and growth of the fetal bovine serum market?
The fetal bovine serum market covered in this report is segmented -

1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human And Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research And Academic Institutes, Biotechnology And Pharmaceutical Industry, Other End-Users

Subsegments:
1) By Charcoal Stripped: Standard Charcoal Stripped FBS, Heat-Inactivated Charcoal Stripped FBS
2) By Chromatographic: Ion Exchange Chromatography Purified FBS, Affinity Chromatography Purified FBS
3) By Dialyzed Fetal Bovine Serum: Standard Dialyzed FBS, Heat-Inactivated Dialyzed FBS
4) By Exosome Depleted: Standard Exosome Depleted FBS, Heat-Inactivated Exosome Depleted FBS
5) By Stem Cell: Stem Cell Grade FBS, Knockout Serum Replacement
6) By Other Products: Serum from Specific Animal Breeds, Custom-Processed FBS

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4109

Which region dominates the fetal bovine serum market?
North America was the largest region in the fetal bovine serum market in 2024. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the fetal bovine serum industry growth?
Major companies operating in the fetal bovine serum market include Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=4109&type=smp

What Is Covered In The Fetal Bovine Serum Global Market Report?

•Market Size Forecast: Examine the fetal bovine serum market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the fetal bovine serum market for a structured understanding.
•Key Players Overview: Analyze major players in the fetal bovine serum market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the fetal bovine serum market.
•Segment Contributions: Evaluate how different segments drive overall growth in the fetal bovine serum market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the fetal bovine serum market.
•Industry Challenges: Identify potential risks and obstacles affecting the fetal bovine serum market.
•Competitive Landscape: Review strategic developments in the fetal bovine serum market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.